Abstract: Detecting nucleic acid sequences in a sample, such as the detection of pathogenic organisms in clinical samples. More specifically, detecting an infection caused by a pathogenic organism such as a virus or a bacterium in a clinical specimen by means of amplifying and detecting specific nucleic acid sequences from said pathogenic organism. A multiplex assay with the possibility to determine about 30 different target nucleic acid sequences in a single one-tube assay combined with real-time probe detection.
Type:
Grant
Filed:
April 23, 2015
Date of Patent:
December 6, 2016
Assignee:
Pathofinder Holding B.V.
Inventors:
Martinus Gerardus Cecilia Maria Reijans, Gijs Josephus Henricus Dingemans, Augustinus Franciscus Maria Simons, Antonia Alberdina Theodora Petronella Brink
Abstract: The invention is in the technical field of detecting nucleic acid sequences in a sample, such as the detection of pathogenic organisms in clinical samples. More specifically, the invention relates to the field of detecting an infection caused by a pathogenic organism such as a virus or a bacterium in a clinical specimen by amplifying and detecting specific nucleic acid sequences from the pathogenic organism. It provides a multiplex assay with the possibility to determine about 30 different target nucleic acid sequences in a single one-tube assay combined with real-time probe detection. The method employs multiplex ligation dependent Probe Amplification (MLPA) employing labelled primers in combination with labelled, probes and detection of the fluorescence.
Type:
Grant
Filed:
July 10, 2008
Date of Patent:
December 29, 2015
Assignee:
Pathofinder Holding B.V.
Inventors:
Martinus Gerardus Cecilia Maria Reijans, Gijs Josephus Henricus Dingemans, Augustinus Franciscus Maria Simons